KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Other Gross PP&E Adjustments: 2012-2014

Historic Other Gross PP&E Adjustments for Biocryst Pharmaceuticals (BCRX) over the last 1 years, with Dec 2014 value amounting to $7.1 million.

  • Biocryst Pharmaceuticals' Other Gross PP&E Adjustments fell 21.75% to $7.1 million in Q4 2014 from the same period last year, while for Dec 2014 it was $16.3 million, marking a year-over-year decrease of 7.45%. This contributed to the annual value of $7.1 million for FY2014, which is 21.75% down from last year.
  • As of Q4 2014, Biocryst Pharmaceuticals' Other Gross PP&E Adjustments stood at $7.1 million, which was down 21.75% from $9.1 million recorded in Q4 2013.
  • Biocryst Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $9.1 million during Q4 2013, with a 5-year trough of -$1.12 in Q1 2013.
  • In the last 3 years, Biocryst Pharmaceuticals' Other Gross PP&E Adjustments had a median value of $7.1 million in 2014 and averaged $4.9 million.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first rose by 7.98% in 2013, then declined by 21.75% in 2014.
  • Biocryst Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at $8.5 million in 2012, then climbed by 7.98% to $9.1 million in 2013, then dropped by 21.75% to $7.1 million in 2014.
  • Its last three reported values are $7.1 million in Q4 2014, $9.1 million for Q4 2013, and -$0.05 during Q2 2013.